img

Global Ivosidenib Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ivosidenib Drugs Market Research Report 2024

Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
According to Mr Accuracy reports new survey, global Ivosidenib Drugs market is projected to reach US$ 238.5 million in 2029, increasing from US$ 175.3 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ivosidenib Drugs market research.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ivosidenib Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Servier Pharmaceuticals
Segment by Type
60 Tablets
30 Tablets

Segment by Application


Hospital
Pharmacy

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ivosidenib Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Ivosidenib Drugs Market Overview
1.1 Product Overview and Scope of Ivosidenib Drugs
1.2 Ivosidenib Drugs Segment by Type
1.2.1 Global Ivosidenib Drugs Market Value Comparison by Type (2024-2034)
1.2.2 60 Tablets
1.2.3 30 Tablets
1.3 Ivosidenib Drugs Segment by Application
1.3.1 Global Ivosidenib Drugs Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Ivosidenib Drugs Market Size Estimates and Forecasts
1.4.1 Global Ivosidenib Drugs Revenue 2018-2029
1.4.2 Global Ivosidenib Drugs Sales 2018-2029
1.4.3 Global Ivosidenib Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Ivosidenib Drugs Market Competition by Manufacturers
2.1 Global Ivosidenib Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Ivosidenib Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Ivosidenib Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Ivosidenib Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Ivosidenib Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ivosidenib Drugs, Product Type & Application
2.7 Ivosidenib Drugs Market Competitive Situation and Trends
2.7.1 Ivosidenib Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ivosidenib Drugs Players Market Share by Revenue
2.7.3 Global Ivosidenib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ivosidenib Drugs Retrospective Market Scenario by Region
3.1 Global Ivosidenib Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Ivosidenib Drugs Global Ivosidenib Drugs Sales by Region: 2018-2029
3.2.1 Global Ivosidenib Drugs Sales by Region: 2018-2024
3.2.2 Global Ivosidenib Drugs Sales by Region: 2024-2029
3.3 Global Ivosidenib Drugs Global Ivosidenib Drugs Revenue by Region: 2018-2029
3.3.1 Global Ivosidenib Drugs Revenue by Region: 2018-2024
3.3.2 Global Ivosidenib Drugs Revenue by Region: 2024-2029
3.4 North America Ivosidenib Drugs Market Facts & Figures by Country
3.4.1 North America Ivosidenib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Ivosidenib Drugs Sales by Country (2018-2029)
3.4.3 North America Ivosidenib Drugs Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Ivosidenib Drugs Market Facts & Figures by Country
3.5.1 Europe Ivosidenib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Ivosidenib Drugs Sales by Country (2018-2029)
3.5.3 Europe Ivosidenib Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ivosidenib Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Ivosidenib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Ivosidenib Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Ivosidenib Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ivosidenib Drugs Market Facts & Figures by Country
3.7.1 Latin America Ivosidenib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Ivosidenib Drugs Sales by Country (2018-2029)
3.7.3 Latin America Ivosidenib Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ivosidenib Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Ivosidenib Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Ivosidenib Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Ivosidenib Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ivosidenib Drugs Sales by Type (2018-2029)
4.1.1 Global Ivosidenib Drugs Sales by Type (2018-2024)
4.1.2 Global Ivosidenib Drugs Sales by Type (2024-2029)
4.1.3 Global Ivosidenib Drugs Sales Market Share by Type (2018-2029)
4.2 Global Ivosidenib Drugs Revenue by Type (2018-2029)
4.2.1 Global Ivosidenib Drugs Revenue by Type (2018-2024)
4.2.2 Global Ivosidenib Drugs Revenue by Type (2024-2029)
4.2.3 Global Ivosidenib Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Ivosidenib Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Ivosidenib Drugs Sales by Application (2018-2029)
5.1.1 Global Ivosidenib Drugs Sales by Application (2018-2024)
5.1.2 Global Ivosidenib Drugs Sales by Application (2024-2029)
5.1.3 Global Ivosidenib Drugs Sales Market Share by Application (2018-2029)
5.2 Global Ivosidenib Drugs Revenue by Application (2018-2029)
5.2.1 Global Ivosidenib Drugs Revenue by Application (2018-2024)
5.2.2 Global Ivosidenib Drugs Revenue by Application (2024-2029)
5.2.3 Global Ivosidenib Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Ivosidenib Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Servier Pharmaceuticals
6.1.1 Servier Pharmaceuticals Corporation Information
6.1.2 Servier Pharmaceuticals Description and Business Overview
6.1.3 Servier Pharmaceuticals Ivosidenib Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Servier Pharmaceuticals Ivosidenib Drugs Product Portfolio
6.1.5 Servier Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ivosidenib Drugs Industry Chain Analysis
7.2 Ivosidenib Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ivosidenib Drugs Production Mode & Process
7.4 Ivosidenib Drugs Sales and Marketing
7.4.1 Ivosidenib Drugs Sales Channels
7.4.2 Ivosidenib Drugs Distributors
7.5 Ivosidenib Drugs Customers
8 Ivosidenib Drugs Market Dynamics
8.1 Ivosidenib Drugs Industry Trends
8.2 Ivosidenib Drugs Market Drivers
8.3 Ivosidenib Drugs Market Challenges
8.4 Ivosidenib Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Ivosidenib Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Ivosidenib Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Ivosidenib Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Ivosidenib Drugs Sales (Units) of Key Manufacturers (2018-2024)
Table 5. Global Ivosidenib Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Ivosidenib Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Ivosidenib Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Ivosidenib Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Ivosidenib Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Ivosidenib Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ivosidenib Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Ivosidenib Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ivosidenib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ivosidenib Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ivosidenib Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Ivosidenib Drugs Sales by Region (2018-2024) & (Units)
Table 18. Global Ivosidenib Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Ivosidenib Drugs Sales by Region (2024-2029) & (Units)
Table 20. Global Ivosidenib Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Ivosidenib Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Ivosidenib Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Ivosidenib Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Ivosidenib Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Ivosidenib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Ivosidenib Drugs Sales by Country (2018-2024) & (Units)
Table 27. North America Ivosidenib Drugs Sales by Country (2024-2029) & (Units)
Table 28. North America Ivosidenib Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Ivosidenib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Ivosidenib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Ivosidenib Drugs Sales by Country (2018-2024) & (Units)
Table 32. Europe Ivosidenib Drugs Sales by Country (2024-2029) & (Units)
Table 33. Europe Ivosidenib Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Ivosidenib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Ivosidenib Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Ivosidenib Drugs Sales by Region (2018-2024) & (Units)
Table 37. Asia Pacific Ivosidenib Drugs Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Ivosidenib Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Ivosidenib Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Ivosidenib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Ivosidenib Drugs Sales by Country (2018-2024) & (Units)
Table 42. Latin America Ivosidenib Drugs Sales by Country (2024-2029) & (Units)
Table 43. Latin America Ivosidenib Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Ivosidenib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Ivosidenib Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Ivosidenib Drugs Sales by Country (2018-2024) & (Units)
Table 47. Middle East & Africa Ivosidenib Drugs Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Ivosidenib Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Ivosidenib Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Ivosidenib Drugs Sales (Units) by Type (2018-2024)
Table 51. Global Ivosidenib Drugs Sales (Units) by Type (2024-2029)
Table 52. Global Ivosidenib Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Ivosidenib Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Ivosidenib Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Ivosidenib Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Ivosidenib Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Ivosidenib Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Ivosidenib Drugs Price (USD/Unit) by Type (2018-2024)
Table 59. Global Ivosidenib Drugs Price (USD/Unit) by Type (2024-2029)
Table 60. Global Ivosidenib Drugs Sales (Units) by Application (2018-2024)
Table 61. Global Ivosidenib Drugs Sales (Units) by Application (2024-2029)
Table 62. Global Ivosidenib Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Ivosidenib Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Ivosidenib Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Ivosidenib Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Ivosidenib Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Ivosidenib Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Ivosidenib Drugs Price (USD/Unit) by Application (2018-2024)
Table 69. Global Ivosidenib Drugs Price (USD/Unit) by Application (2024-2029)
Table 70. Servier Pharmaceuticals Corporation Information
Table 71. Servier Pharmaceuticals Description and Business Overview
Table 72. Servier Pharmaceuticals Ivosidenib Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Servier Pharmaceuticals Ivosidenib Drugs Product
Table 74. Servier Pharmaceuticals Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Ivosidenib Drugs Distributors List
Table 78. Ivosidenib Drugs Customers List
Table 79. Ivosidenib Drugs Market Trends
Table 80. Ivosidenib Drugs Market Drivers
Table 81. Ivosidenib Drugs Market Challenges
Table 82. Ivosidenib Drugs Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ivosidenib Drugs
Figure 2. Global Ivosidenib Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Ivosidenib Drugs Market Share by Type in 2022 & 2029
Figure 4. 60 Tablets Product Picture
Figure 5. 30 Tablets Product Picture
Figure 6. Global Ivosidenib Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Ivosidenib Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Global Ivosidenib Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Ivosidenib Drugs Market Size (2018-2029) & (US$ Million)
Figure 12. Global Ivosidenib Drugs Sales (2018-2029) & (Units)
Figure 13. Global Ivosidenib Drugs Average Price (USD/Unit) & (2018-2029)
Figure 14. Ivosidenib Drugs Report Years Considered
Figure 15. Ivosidenib Drugs Sales Share by Manufacturers in 2022
Figure 16. Global Ivosidenib Drugs Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Ivosidenib Drugs Players: Market Share by Revenue in 2022
Figure 18. Ivosidenib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Ivosidenib Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Ivosidenib Drugs Sales Market Share by Country (2018-2029)
Figure 21. North America Ivosidenib Drugs Revenue Market Share by Country (2018-2029)
Figure 22. the United States Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Ivosidenib Drugs Sales Market Share by Country (2018-2029)
Figure 25. Europe Ivosidenib Drugs Revenue Market Share by Country (2018-2029)
Figure 26. Germany Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. UK Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Ivosidenib Drugs Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Ivosidenib Drugs Revenue Market Share by Region (2018-2029)
Figure 33. China Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Ivosidenib Drugs Sales Market Share by Country (2018-2029)
Figure 43. Latin America Ivosidenib Drugs Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Ivosidenib Drugs Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Ivosidenib Drugs Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Ivosidenib Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Ivosidenib Drugs by Type (2018-2029)
Figure 53. Global Revenue Market Share of Ivosidenib Drugs by Type (2018-2029)
Figure 54. Global Ivosidenib Drugs Price (USD/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Ivosidenib Drugs by Application (2018-2029)
Figure 56. Global Revenue Market Share of Ivosidenib Drugs by Application (2018-2029)
Figure 57. Global Ivosidenib Drugs Price (USD/Unit) by Application (2018-2029)
Figure 58. Ivosidenib Drugs Value Chain
Figure 59. Ivosidenib Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed